A protocol gets approved on Tuesday. By Friday, three different teams are manually retyping the same eligibility criteria, visit schedule, and endpoint definitions into EDC, CTMS, and randomization systems. TransCelerate reports an average four-month lag between protocol approval and study startup, with document-based duplication as one contributor.
The Unified Study Definitions Model (USDM) is the CDISC and TransCelerate standard built to stop this duplication. It is not software, it is a shared data model that lets EDC, CTMS, and protocol authoring tools speak the same language. Instead of each vendor inventing its own internal representation of a protocol, USDM defines standardized classes and attributes for populations, interventions, activities, and encounters. Any conformant system can then produce, consume, or exchange that structured information without manual retyping.
The catch: two systems reporting the same USDM version are not automatically interoperable. Vendor-specific mappings, validation, and human review of eligibility and endpoint definitions are still required. USDM defines what a study looks like as data and how to move it. It does not, on its own, auto-populate your EDC or CTMS screens. Study build and data management staff still review the result, especially where a mapping error would be costly to miss.